TITLE

4. Axillary dissection

PUB. DATE
February 1998
SOURCE
CMAJ: Canadian Medical Association Journal;02/10/98 Supplement, Vol. 158, pS22
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To provide information needed by patients with breast cancer (stages I and II) and their physicians when deciding whether axillary dissection should be carried out. Options: No axillary surgery; removal of all axillary lymph nodes; removal of level 1 and 2 nodes; axillary "sampling." Outcomes: Accurate determination of stage of cancer, resulting in better-informed therapeutic decisions; reduction of recurrence in axillary lymph nodes; improved survival. Evidence: A systematic review of English language literature based on MEDLINE and CANCERLIT databases to September 1996, with nonsystematic review continued to June 1997. The nature of the evidence or opinion is classified as shown on page S2. Benefits: Optimal therapy, with maximal survival and minimal local recurrence. Harms: Increased postsurgical morbidity. Recommendations: • Removal and pathological examination of axillary lymph nodes should be standard procedure for patients with early, invasive breast cancer. • For accurate staging and to reduce the risk of recurrence in the axilla, level 1 and level 2 nodes should be removed. • Patients should be made fully aware of the frequency and severity of the potential complications of axillary dissection. • Irradiation of the axilla should carried out with caution after axillary dissection. • Omission of axillary dissection may be considered when the risk of axillary metastasis is very low or when knowledge of node status will have no influence on therapy. • Patients should be offered the opportunity to participate in clinical trials whenever possible. Validation: Initial draft guidelines were successively reviewed and revised by a writing committee, expert primary reviewers, secondary reviewers chosen from all regions of Canada and by the Steering Committee. The final document reflects a consensus of all these contributors. Sponsor: The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer was convened by Health Canada. Completion date: July 1, 1997
ACCESSION #
22328720

 

Related Articles

  • Interrogating a Multifactorial Model of Breast Conserving Therapy with Clinical Data. Salmon, Remi; Garbey, Marc; Moore, Linda W.; Bass, Barbara L. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Most women with early stage breast cancer do not require removal of the entire breast to treat their cancer; instead, up to 70% of women can be effectively and safely treated by breast conserving therapy (BCT) with surgical removal of the tumor only (lumpectomy) followed by radiation treatment...

  • Effects of high-energy ionizing radiation on organ systems in human medicine. Visnovcova, N; Simera, M; Visnovcova, N Jr; Jakusova, V; Jakus, J // Acta Medica Martiniana;Nov2013, Vol. 13 Issue 3, p23 

    The aim of our study was to investigate acute post-radiation changes after therapy with ionizing radiation manifested by erythema or dry, squamous and scurfy skin on a breast. We observed 100 female patients suffering from an early stage of breast carcinoma. The entering criteria were: age below...

  • Predicting the Likelihood of Additional Nodal Metastases in Breast Carcinoma Patients With Positive Sentinel Node Biopsy. Mustać, Elvira; Matušan-Ilijaš, Koviljka; Marijić, Blažen; Smokvina, Miljenko; Jonjic, Nives // International Journal of Surgical Pathology;Feb2010, Vol. 18 Issue 1, p36 

    Axillary lymph node dissection (ALND) is an important procedure in the staging of breast cancer patients. However, it is associated with a significant morbidity rate. In addition, using early diagnosis a high number of cases with negative lymph nodes can be identified. A lymph node defined as...

  • Validation of the Shortened COPE for use with Breast Cancer Patients Undergoing Radiation Therapy. Fillion, Lise; Kovacs, Adrienne H.; Gagnon, Pierre; Endler, Norman S. // Current Psychology;Spring2002, Vol. 21 Issue 1, p17 

    To study the relationship between cancer and emotional adjustment, investigation of situation-specific coping behaviors with respect to narrowly defined stressors has recently been promoted. The development and validation of shorter instruments, designed to facilitate completion by clinical...

  • Adjuvant Radiation after Modified Radical Mastectomy for Breast Cancer Fails to Prolong Survival. Geisler, D.P.; Boyle, M.J.; Malnar, K.F.; Melichar, R.M.; McGee, J.M.; Nolen, M.G.; Broughan, T.A. // American Surgeon;May2000, Vol. 66 Issue 5, p452 

    Recent literature has reported improved local disease control and overall survival in premenopausal node-positive (stage II, and III) breast cancer patients undergoing modified radical mastectomy (MRM) using radiation therapy (RT) combined with chemotherapy. To assess the efficacy of...

  • Breast-conserving therapy plus radiation improved survival in patients with early-stage disease.  // Hem/Onc Today;4/10/2013, Vol. 14 Issue 7, p14 

    The article discusses research being done on the effect of breast-conserving therapy plus radiation on patients with early-stage breast cancer.

  • Hypofractionated radiotherapy safe, effective for early breast cancer.  // Hem/Onc Today;10/25/2013, Vol. 14 Issue 20, p55 

    The article presents the results of two randomized multicenter studies as of late October 2013, which showed that hypofractionated radiotherapy administered in correct doses is effective for patients with early breast cancer.

  • Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells. Kesler, Cristina; Kuo, Angera; Wong, Hon-Kit; Masuck, David; Shah, Jennifer; Kozak, Kevin; Held, Kathryn; Padera, Timothy // Angiogenesis;Apr2014, Vol. 17 Issue 2, p419 

    Radiation therapy after lymph node dissection increases the risk of developing painful and incurable lymphedema in breast cancer patients. Lymphedema occurs when lymphatic vessels become unable to maintain proper fluid balance. The sensitivity of lymphatic endothelial cells (LECs) to ionizing...

  • The Treatment Decision-Making Process: Age Differences in a Sample of Women Recently Diagnosed... Petrisek, Ann C.; Laliberte, Linda L. // Gerontologist;Oct97, Vol. 37 Issue 5, p598 

    Deals with a study which examined the important areas of the treatment decision-making process and how it varies on patients diagnosed with noncurrent, early-stage breast cancer. Methodology; Treatment decision-making context by age; Decision-making style of patient by age; Factors influencing...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics